ArticleCureus2025
Successful Removal of Subretinal Silicone Oil Using a Vitreous Fluid Control Kit: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silicone oil (SO) is commonly used as a long-term intraocular tamponade in complex retinal detachment cases, but its use may lead to several complications, including glaucoma, keratopathy, cataract, and oil emulsification. Subretinal migration of SO is an uncommon but clinically significant event that can occur through pre-existing or iatrogenic retinal breaks or microscopic defects caused by repeated intraocular manipulation. We report a rare case of subretinal SO migration following pars plana vitrectomy (PPV) that was successfully managed using a direct intraocular approach with a vitreous fluid control (VFC) kit. A 48-year-old male patient presented with decreased vision in the left eye. Fundus examination revealed total rhegmatogenous retinal detachment with proliferative vitreoretinopathy. Initial surgery involved scleral buckling and sulfur hexafluoride gas injection. Due to persistent subretinal fluid, a second PPV was performed with posterior vitreous detachment induction, removal of subretinal bands, PFCL injection, and SO tamponade. Seven days postoperatively, subretinal migration of SO was observed. A third PPV was performed to remove subretinal SO. A retinal incision was created at a location that allowed straight access via a nasal trocar. The 25G cutter failed to aspirate the SO; however, the VFC kit enabled successful removal. The retina remained attached postoperatively. SO removal and intraocular lens fixation were later performed without recurrence. This case demonstrates that strategic intraocular access using VFC-assisted aspiration can enable effective removal of subretinal SO while minimizing surgical damage and emphasizes the importance of careful planning during vitreoretinal surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.